Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.

Oncotarget - 11 Apr 2017

Li Ying, Liu Junru, Huang Beihui, Chen Meilan, Diao Xiangwen, Li Juan

Abstract excerpt

Multiple myeloma (MM) causes osteolytic lesions which can be detected by 18F-fluorodeoxyglucose positron emission tomography/Computed tomography (18F-FDG PET/CT). We prospectively involve 96 Newly diagnosed MM to take PET/CT scan at scheduled treatment time (figure 1), and 18F-FDG uptake of lesion was measured by SUVmax and T/Mmax. All MM patients took bortezomib based chemotherapy as induction and received ASCT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Positron-Emission Tomography

Share to Positron Emission Tomography Computed Tomography

Share to Recurrence

Share to ROC Curve

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 27556189
DOI: 10.18632/oncotarget.11418
PMCID: PMC5421957

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.PMID 27556189Read ↗

Quantitative Imaging and Radiomics in Multiple Myeloma: opportunity or hype?Semantic proximity Read ↗

Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET StudySemantic proximity Read ↗

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases.Semantic proximity Read ↗

High diffuse bone marrow uptake in 18 F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myelomaSemantic proximity Read ↗

An Uncommon Etiology for Pleural Effusion with Rib Lesion in a 78-year-old Woman: A Case ReportSemantic proximity Read ↗

Treatment outcome of newly diagnosed multiple myeloma patients: A retrospective analysis in a resource-limited settingSemantic proximity Read ↗

High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myeloma.Semantic proximity Read ↗

Correlation analysis of circulating myeloma cells with tumor load, angiogenesis and disease progression of multiple myeloma and clinical significanceSemantic proximity Read ↗

[Molecular pathogenesis of myeloma for the therapeutic targets].Semantic proximity Read ↗

Spleen involvement at diagnosis of multiple myeloma: a case report and literature reviewSemantic proximity Read ↗

Bone mineral density utilization in patients with newly diagnosed multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.